TickerFacts.

Citius Pharmaceuticals, Inc. (CTXR): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2018-09-30, while the company's latest annual report covers the year ended 2025-09-30. Its later filings do not report this line under the concept TickerFacts maps.

$75.0K
Year ended 2018-09-30
2016-09-30: $45.0K2017-09-30: $50.0K2018-09-30: $75.0K$75.0K
2016-09-30 Cost of Revenue (USD) 2018-09-30
Period endedCost of RevenueChange YoYSource filing
2018-09-30$75.0K+50.0%2019-12-16, From 2017-10-01
2017-09-30$50.0K+11.1%2019-12-16, From 2016-10-01
2016-09-30$45.0Kn/a2019-12-16, From 2015-10-01